Ligand Pharmaceuticals Inc (LGND)
73.90
+1.58
(+2.18%)
USD |
NASDAQ |
May 03, 16:00
73.90
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Cash from Investing (Quarterly): -10.28M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.28M |
| September 30, 2023 | -19.50M |
| June 30, 2023 | 7.556M |
| March 31, 2023 | 10.55M |
| December 31, 2022 | -7.284M |
| September 30, 2022 | 19.18M |
| June 30, 2022 | 37.85M |
| March 31, 2022 | 113.88M |
| December 31, 2021 | -35.71M |
| September 30, 2021 | -18.22M |
| June 30, 2021 | 19.34M |
| March 31, 2021 | 65.12M |
| December 31, 2020 | -382.20M |
| September 30, 2020 | 332.07M |
| June 30, 2020 | -26.76M |
| March 31, 2020 | 308.54M |
| December 31, 2019 | -63.18M |
| September 30, 2019 | 169.52M |
| June 30, 2019 | 265.80M |
| March 31, 2019 | 94.78M |
| December 31, 2018 | 275.30M |
| September 30, 2018 | -78.25M |
| June 30, 2018 | -586.74M |
| March 31, 2018 | -33.58M |
| December 31, 2017 | -36.17M |
| Date | Value |
|---|---|
| September 30, 2017 | -56.54M |
| June 30, 2017 | 39.20M |
| March 31, 2017 | -25.67M |
| December 31, 2016 | -77.95M |
| September 30, 2016 | 5.078M |
| June 30, 2016 | 18.22M |
| March 31, 2016 | -79.76M |
| December 31, 2015 | -11.48M |
| September 30, 2015 | -26.36M |
| June 30, 2015 | -72.22M |
| March 31, 2015 | -2.797M |
| December 31, 2014 | -1.711M |
| September 30, 2014 | 0.073M |
| June 30, 2014 | 0.609M |
| March 31, 2014 | -0.998M |
| December 31, 2013 | -1.003M |
| September 30, 2013 | -0.245M |
| June 30, 2013 | -3.692M |
| March 31, 2013 | -0.034M |
| December 31, 2012 | -0.072M |
| September 30, 2012 | -2.368M |
| June 30, 2012 | -0.242M |
| March 31, 2012 | 3.945M |
| December 31, 2011 | -2.279M |
| September 30, 2011 | -0.137M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-382.20M
Minimum
Dec 2020
332.07M
Maximum
Sep 2020
41.38M
Average
10.55M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | -4.779M |
| ADMA Biologics Inc | -1.407M |
| Viking Therapeutics Inc | -459.79M |
| Voyager Therapeutics Inc | 26.83M |
| Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.065M |
| Cash from Financing (Quarterly) | 5.315M |
| Free Cash Flow | -4.272M |
| Free Cash Flow Per Share (Quarterly) | -2.415 |
| Free Cash Flow to Equity (Quarterly) | -42.68M |
| Free Cash Flow to Firm (Quarterly) | -42.68M |
| Free Cash Flow Yield | -0.33% |